Regulation is not costless. It can have adverse effects on innovation, on the time required to develop a new product and on an industry's competitiveness. This article estimates the costs of regulating the UK pharmaceutical industry and whether the results are worthwhile.
No takes yet. Share an insight, caveat, or question.
Hartley et al. (1982) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: